Factors influencing the acceptability of automated insulin delivery systems in youths with type 1 diabetes and their parents.

Autor: Franceschi R; Department of Pediatrics, S.Chiara Hospital of Trento, APSS, Trento, Trentino-Alto Adige, Italy., Pertile R; Clinical and Evaluative Epidemiology Unit, Health Management, APSS, Trento, Italy., Marigliano M; Department of Surgery, Dentistry, Pediatrics and Gynecology, Section of Pediatric Diabetes and Metabolism, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy., Mozzillo E; Department of Translational Medical Science, Section of Pediatrics, Università degli Studi di Napoli Federico II, Naples, Italy. Electronic address: enza.mozzillo@unina.it., Maffeis C; Department of Surgery, Dentistry, Pediatrics and Gynecology, Section of Pediatric Diabetes and Metabolism, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy., Zaffani S; Department of Surgery, Dentistry, Pediatrics and Gynecology, Section of Pediatric Diabetes and Metabolism, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy., Dusini C; Department of Pediatrics, S.Chiara Hospital of Trento, APSS, Trento, Trentino-Alto Adige, Italy., Antonelli A; Department of Maternal and Child Health, UOSD Regional Center of Pediatric Diabetology, 'SS Annunziata' Hospital, Chieti, Italy., Maltoni G; Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Candia FD; Department of Translational Medical Science, Section of Pediatrics, Università degli Studi di Napoli Federico II, Naples, Italy., Cantarelli E; Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Minuto N; Pediatric Clinic, IRCCS Giannina Gaslini, Department of Neuroscience Rehabilitation Ophtalmology Genetics, Maternal and Child Health, University of Genoa, Genova, Italy., Bassi M; Pediatric Clinic, IRCCS Giannina Gaslini, Department of Neuroscience Rehabilitation Ophtalmology Genetics, Maternal and Child Health, University of Genoa, Genova, Italy., Rabbone I; Division of Pediatrics, Department of Health Sciences, University of Piemonte Orientale, Novara, Italy., Savastio S; Division of Pediatrics, Department of Health Sciences, University of Piemonte Orientale, Novara, Italy., Passanisi S; Department of Human Pathology of Adulthood and Childhood G. Barresi, University of Messina, Messina, Italy., Lombardo F; Department of Human Pathology of Adulthood and Childhood G. Barresi, University of Messina, Messina, Italy., Cherubini V; Department of Women's and Children's Health, Azienda Ospedaliero-Universitaria, Ospedali Riuniti di Ancona, 'G. Salesi Hospital', Ancona, Italy., Saltarelli MA; Department of Maternal and Child Health, UOSD Regional Center of Pediatric Diabetology, 'SS Annunziata' Hospital, Chieti, Italy., Tumini S; Department of Maternal and Child Health, UOSD Regional Center of Pediatric Diabetology, 'SS Annunziata' Hospital, Chieti, Italy.
Jazyk: angličtina
Zdroj: Diabetes research and clinical practice [Diabetes Res Clin Pract] 2024 Dec 13, pp. 111962. Date of Electronic Publication: 2024 Dec 13.
DOI: 10.1016/j.diabres.2024.111962
Abstrakt: Aims: New technology has been reported as a factor driving people to choose an automatic insulin delivery system (AIDs) and to sustain its acceptance. We aimed to explore the role of continuous glucose monitoring (CGM) technology (instant scanning vs. real-time) and insulin treatment modality to determine the future acceptance of AIDs among T1D individuals.
Methods: 239 consecutively enrolled T1D youth and their parents returned the AP questionnaire. All individuals were on CGM, using multiple daily injections (MDI) or sensor-augmented pump (SAP) therapy.
Results: The AP-acceptance was more than neutral, with mean overall scores of 3.91 ± 0.47 and 3.99 ± 0.43 (p = 0.07), youths and parents, respectively. Domains' analysis revealed high scores in intention to use, usefulness, and trust in AIDs, with favorable expected judgments by others. The items with the highest overall mean scores revealed high glucose control and QoL benefits; the main hassle was the size and discomfort of wearing two devices. Multivariate analysis found that male gender and SAP therapy were associated with a higher AP-acceptance overall score (p = 0.045, 0.015, 0.0001, respectively).
Conclusions: Participants receiving SAP therapy demonstrated higher expectations and optimistic views about AIDs. This treatment modality can act as a trampoline to AIDs despite individuals' glucose control and diabetes history.
Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2024. Published by Elsevier B.V.)
Databáze: MEDLINE
Externí odkaz: